Walid Kamoun, Vice President, Global Head of R&D Oncology at Servier, shared a post on LinkedIn:
“On my way to Boston.
Always excited by the prospect of spending time with the team in Boston and reconnecting in person. This trip will also include two days fully dedicated to oncology strategy with my leadership team, an important moment to align, challenge our thinking, sharpen our priorities and focus on our pipeline of innovative oncology therapies. At Servier, we remain committed to delivering transformative therapies to cancer patients.
All of this is in preparation for ASCO2026 annual meeting. I first attended the ASCO Annual Meeting back in 2013, and I’ve never missed it since. Year after year, it remains a unique forum to exchange ideas, learn from the community, and reflect on how we can collectively move the field forward for patients.
Looking forward to the discussions ahead and to another ASCO that will undoubtedly inspire us to think bigger and act bolder.
While in Boston, I will be mostly in the seaport area.”
Other articles featuring Walid Kamoun on OncoDaily.
